ASPIRIN AND THE SALICYLATESWATSON BUCHANAN W; ROONEY PJ; RENNIE JAN et al.1979; CLIN. RHEUMATIC DIS.; GBR; DA. 1979; VOL. 5; NO 2; PP. 499-539; BIBL. 16 P.Article

Assessment of antirheumatic activity in manBELLAMY, N; WATSON BUCHANAN, W.Baillière's clinical rheumatology. 1990, Vol 4, Num 3, pp 433-465, issn 0950-3579, 33 p.Article

A DOUBLE-BLIND, CROSSOVER TRIAL OF MEFENAMIC ACID, SULINDAC AND FLURBIPROFEN IN RHEUMATOID ARTHRITISSTEPHENS WH; EL GHOBAREY AF; MACLEOD MM et al.1979; CURR. MED. RES. OPINION; GBR; DA. 1979; VOL. 5; NO 10; PP. 754-758; BIBL. 8 REF.Article

THE FORGOTTEN NODULE: COMPLICATIONS OF SACRAL NODULES IN RHEUMATOID ARTHRITIS. = LE NODULE OUBLIE: COMPLICATIONS DE NODULES SACRES DANS L'ARTHRITE RHUMATOIDESTURROCK RD; COWDEN EA; HOWIE E et al.1975; BRIT. MED. J.; G.B.; DA. 1975; NO 5988; PP. 92-93; BIBL. 6 REF.Article

Ankylosing Spondylitis: Yesterday and TodaySPENCER, D. G; STURROCK, R. D; WATSON BUCHANAN, W et al.Medical History London. 1980, Vol 24, Num 1, pp 60-69Article

Fibroblast growth factors in sclerodermaPOTTER, S. R; BIENENSTOCK, J; GOLDSTEIN, S et al.Journal of rheumatology. 1985, Vol 12, Num 6, pp 1129-1135, issn 0315-162XArticle

Clinical evaluation of a sustained release compared to a standard formulation of tiaprofenic acid (Surgam®) in rheumatoid arthritis : a Canadian multicenter studyWATSON BUCHANAN, W; KEAN, W. F; ST-JEAN, J et al.Journal of rheumatology. 1991, Vol 18, Num 7, pp 1046-1054, issn 0315-162XArticle